SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-13-039994
Filing Date
2013-07-17
Accepted
2013-07-17 17:58:44
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v350166-form4.html 4/A  
1 OWNERSHIP DOCUMENT v350166-form4.xml 4/A 11240
  Complete submission text file 0001144204-13-039994.txt   12723
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 S. SIXTH STREEET SUITE 3620 MINNEAPOLIS MN 55402
Business Address
Zisson Alex (Reporting) CIK: 0001512058 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35119 | Film No.: 13973447